Inventor · disambiguated record
Michael Kaplitt
Also filed as: KAPLITT MICHAEL · KAPLITT MICHAEL G
14 granted patents·12 pending applications·784 citations·filing 1993–2020
93Inventor score
Files withNEUROLOGIX INC6UNIV ROCKEFELLER6CIRCUIT THERAPEUTICS INC4KAPLITT MICHAEL G4KAPLITT MICHAEL2
Top patents by PatentIndex Score
26 records- 0198US6180613B1AAV-mediated delivery of DNA to cells of the nervous systemUNIV ROCKEFELLER·Filed 1995·Granted Jan 30, 2001·488 cites·15 claims
- 0297US6503888B1AAV-mediated delivery of DNA to cells of the nervous systemUNIV ROCKEFELLER·Filed 2000·Granted Jan 7, 2003·140 cites·26 claims
- 0391US7955595B2Glutamic acid decarboxylase (GAD) based delivery systemNEUROLOGIX INC·Filed 2010·Granted Jun 7, 2011·9 cites·6 claims
- 0490US6780409B2Glutamic acid decarboxylase (GAD) based delivery systemUNIV JEFFERSON·Filed 2001·Granted Aug 24, 2004·21 cites·14 claims
- 0578US8067156B2Method for generating replication defective viral vectors that are helper freeKAPLITT MICHAEL G·Filed 2002·Granted Nov 29, 2011·12 cites·37 claims
- 0673US8021838B2Transcriptional regulation of target genesUNIV ROCKEFELLER·Filed 2006·Granted Sep 20, 2011·1 cites·9 claims
- 0773US8017385B2Use of apotosis inhibiting compounds in degenerative neurological disordersNEUROLOGIX INC·Filed 2005·Granted Sep 13, 2011·3 cites·12 claims
- 0872US8182460B2Infusion device and method for infusing material into the brain of a patientKAPLITT MICHAEL G·Filed 2010·Granted May 22, 2012·6 cites·16 claims
- 0972US6162796AMethod for transferring genes to the heart using AAV vectorsUNIV ROCKEFELLER·Filed 1995·Granted Dec 19, 2000·42 cites·36 claims
- 1071US6106824AExpression of growth associated protein B-50/GAP-43 in vitro and in vivoUNIV ROCKEFELLER·Filed 1996·Granted Aug 22, 2000·38 cites·9 claims
- 1166US7645446B2Glutamic acid decarboxylase (GAD) based delivery systemNEUROLOGIX INC·Filed 2004·Granted Jan 12, 2010·2 cites·8 claims
- 1263US6040172ADefective DNA viral vector comprising a neural tissue-specific promoter for in vivo expression of a geneUNIV ROCKEFELLER·Filed 1993·Granted Mar 21, 2000·22 cites·21 claims
- 1358US7695959B2Glutamic acid decarboxylase (GAD) based delivery systemsNEUROLOGIX INC·Filed 2004·Granted Apr 13, 2010·0 cites·8 claims
- 1455US2011207802A1Glutamic acid decarboxylase (gad) based delivery systemNEUROLOGIX INC·Filed 2011·Application pending·0 cites
- 1553US2021301306A1Gene therapy methods to control organ functionUNIV CORNELL·Filed 2019·Application pending·0 cites
- 1651US8642341B2Materials and methods for gene mediated therapy of psychiatric disordersKAPLITT MICHAEL·Filed 2008·Granted Feb 4, 2014·0 cites·13 claims
- 1748US2015360050A1Optogenetic therapies for movement disordersCIRCUIT THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1848US2003087264A1Transcriptional regulation of target genesFiled 2002·Application pending·0 cites
- 1947US2006129126A1Infusion device and method for infusing material into the brain of a patientKAPLITT MICHAEL G·Filed 2005·Application pending·0 cites
- 2046US2022168445A1Focused ultrasound for non-invasive focal gene delivery to the mammalian brainUNIV CORNELL·Filed 2020·Application pending·0 cites
- 2145US2015360049A1Optogenetic therapies for movement disordersCIRCUIT THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2244US2006228776A1PINK-1 promoterNEUROLOGIX INC·Filed 2005·Application pending·0 cites
- 2343US2012117674A1Method for generating replication defective viral vectors that are helper freeKAPLITT MICHAEL G·Filed 2011·Application pending·0 cites
- 2441US2017182191A1System and method for optogenetic therapyCIRCUIT THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2541US2016030765A1System and method for optogenetic therapyCIRCUIT THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2636US2012039991A1Use of apoptosis inhibiting compounds in degenerative neurological disordersKAPLITT MICHAEL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Kaplitt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →